Outset Medical (OM) to Release Quarterly Earnings on Wednesday

Outset Medical (NASDAQ:OM) will issue its quarterly earnings data after the market closes on Wednesday, May 8th. Analysts expect the company to announce earnings of ($0.60) per share for the quarter. Parties interested in registering for the company’s conference call can do so using this link.

Outset Medical (NASDAQ:OM) last issued its quarterly earnings data on Wednesday, February 21st. The company reported ($0.77) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.74) by ($0.03). The firm had revenue of $30.51 million for the quarter, compared to analysts’ expectations of $30.40 million. Outset Medical had a negative return on equity of 102.50% and a negative net margin of 132.54%. On average, analysts expect Outset Medical to post $-2 EPS for the current fiscal year and $-2 EPS for the next fiscal year.

Outset Medical Stock Performance

Shares of OM stock opened at $3.14 on Monday. The company has a quick ratio of 4.37, a current ratio of 5.26 and a debt-to-equity ratio of 1.06. Outset Medical has a 1 year low of $1.92 and a 1 year high of $24.13. The stock’s 50-day moving average is $2.48 and its two-hundred day moving average is $3.75.

Analyst Upgrades and Downgrades

OM has been the topic of a number of analyst reports. CL King raised Outset Medical from a “neutral” rating to a “buy” rating and set a $6.00 price objective on the stock in a report on Friday, April 5th. Royal Bank of Canada downgraded Outset Medical from an “outperform” rating to a “sector perform” rating and cut their price objective for the stock from $14.00 to $6.00 in a research report on Friday, January 12th. Finally, BTIG Research initiated coverage on Outset Medical in a report on Monday, April 8th. They issued a “buy” rating and a $6.00 price target for the company. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $5.42.

Outset Medical Company Profile

Outset Medical, Inc, a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables.